ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

ACR Convergence 2024

November 14-19, 2024. Washington, DC.

View by Number View by Title View Sessions

Tuesday, November 19, 2024

8:00AM-9:30AM
Abstract Number: L17
Allogenic CD19 CAR NK Cells Therapy in Refractory Systemic Lupus Erythematosus: An Open-label, Single Arm, Prospective and Interventional Clinical Trial
Late-Breaking Abstracts (L15–L20)
8:00AM-9:30AM
Abstract Number: L20
Automated Ultrasound System ARTHUR with AI Analysis DIANA Matches Expert Rheumatologist in Hand Joint Assessment of Rheumatoid Arthritis Patients
Late-Breaking Abstracts (L15–L20)
8:00AM-9:30AM
Abstract Number: L18
CCL19+ Fibroblasts Orchestrate Fibrotic Microenvironment via CCL19-CCR7 Axis in Systemic Sclerosis
Late-Breaking Abstracts (L15–L20)
8:00AM-9:30AM
Abstract Number: L16
Dapirolizumab Pegol Demonstrated Significant Improvement in Systemic Lupus Erythematosus Disease Activity: Efficacy and Safety Results of a Phase 3 Trial
Late-Breaking Abstracts (L15–L20)
8:00AM-9:30AM
Abstract Number: L19
Efficacy and Safety of Emapalumab in Children and Adults with Macrophage Activation Syndrome (MAS) in Still’s Disease: Results from a Phase 3 Study and a Pooled Analysis of Two Prospective Trials
Late-Breaking Abstracts (L15–L20)
8:00AM-9:30AM
Abstract Number: L15
LEVI-04, a Novel neurotrophin-3 Inhibitor, Substantially Improves Pain and Function Without Deleterious Effects on Joint Structure in People with Knee Osteoarthritis: A Randomized Controlled Phase II Trial
Late-Breaking Abstracts (L15–L20)
11:00AM-12:30PM
Abstract Number: 2659
A Comprehensive Approach Utilizing a Combination of Genetics, Cytological Analysis, and Imaging Techniques to Speed up the Diagnostic Process in VEXAS Patients
Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases II
11:00AM-12:30PM
Abstract Number: 2663
ADI-001: An Allogeneic CD20-targeted γδ CAR T Cell Therapy with Potential for Improved Tissue Homing in Autoimmune Indications
Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases II
11:00AM-12:30PM
Abstract Number: 2690
ANCA IgG Promotion of Neutrophil Recruitment, Migration and Vascular Damage in ANCA Associated Vasculitis May Be Enhanced by Hypoxia
Abstracts: Vasculitis – ANCA-Associated II
11:00AM-12:30PM
Abstract Number: 2667
Anti-Mi2 Autoantibodies in Dermatomyositis Patients Also Recognize Autoimmune Regulator (AIRE) Protein
Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science II
11:00AM-12:30PM
Abstract Number: 2684
Assessment of Skin in Patients with Systemic Sclerosis Using High Frequency Ultrasound : A Comparative Study with Histology and Clinical Parameters of Skin Disease
Abstracts: Systemic Sclerosis & Related Disorders – Clinical III
11:00AM-12:30PM
Abstract Number: 2685
Association Between Gastrointestinal Bacterial Species and Radiological Features of Systemic Sclerosis-Interstitial Lung Disease (SSc-ILD): A Multicenter Study from the SSc Microbiome Consortium Project
Abstracts: Systemic Sclerosis & Related Disorders – Clinical III
11:00AM-12:30PM
Abstract Number: 2681
Association of Social Determinants of Health with Systemic Lupus Erythematosus in the United States: Nationally Representative Estimates for 2017-2021
Abstracts: SLE – Diagnosis, Manifestations, & Outcomes III: Targets, Outcomes & Comorbidity
11:00AM-12:30PM
Abstract Number: 2694
Associations Between Immune Checkpoint Molecules and Nasal Microbiome in ANCA-associated Vasculitis
Abstracts: Vasculitis – ANCA-Associated II
11:00AM-12:30PM
Abstract Number: 2665
Autoantibody Titers Against Specific Epitope Peptides Predict Treatment Resistance in Interstitial Lung Disease Associated with Anti-MDA5 Dermatomyositis
Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science II
  • 1
  • 2
  • 3
  • Next Page

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology